DEFA14AThe Ballot
TEVA PHARMACEUTICAL INDUSTRIES LTD files DEFA14A
Filed Mar 31, 2026 · 3mo ago · Accession 0001193125-26-134787
Plain English
Teva Pharmaceutical Industries Limited is holding its 2026 Annual Meeting of Shareholders on May 28, 2026, to vote on three proposals, including the appointment of a director, advisory approval of executive compensation, and ratification of the independent auditor. The Board of Directors recommends a FOR vote on all proposals.
Filing details
- Ticker
- TEVA
- CIK
- 818686
- Form type
- DEFA14A
- Filing date
- Mar 31, 2026
- Report date
- —
- Document
- d13996ddefa14a.htm
- Size
- 1.8 MB